KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma

Table 2

Univariate and multivariate analysis of the associations of overall survival with various clinicopathologic parameters and KDELR3 expression in uveal melanoma patients.

Characteristics	Total ()	Univariate analysis		Multivariate analysis
		Hazard ratio (95% CI)	value	Hazard ratio (95% CI)	value
Pathologic T stage	80
T2	14	Reference
T3	32	3.138 (0.401-24.558)	0.276
T4	34	4.572 (0.590-35.428)	0.146
Pathologic N stage	79
N0	52	Reference
NX	27	0.890 (0.360-2.198)	0.800
Pathologic M stage	78
M0	51	Reference
M1 and MX	27	0.924 (0.373-2.287)	0.865
Pathologic stage	79
Stage II	39	Reference
Stage III and stage IV	40	1.502 (0.629-3.585)	0.360
Age	80
≤60	40	Reference
>60	40	2.123 (0.914-4.933)	0.080	2.528 (1.055-6.061)	0.038
Gender	80
Female	35	Reference
Male	45	1.542 (0.651-3.652)	0.325
KDELR3	80
Low	40	Reference
High	40	12.517 (3.685-42.512)	<0.001	13.397 (3.931-45.657)	<0.001